Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1-Reference-Cited by-同舟云学术

Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1

Published:2014-02 Issue:2 Volume:22 Page:464-475
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Borthwick Nicola,Ahmed Tina,Ondondo Beatrice,Hayes Peter,Rose Annie,Ebrahimsa Umar,Hayton Emma-Jo,Black Antony,Bridgeman Anne,Rosario Maximillian,Hill Adrian VS,Berrie Eleanor,Moyle Sarah,Frahm Nicole,Cox Josephine,Colloca Stefano,Nicosia Alfredo,Gilmour Jill,McMichael Andrew J,Dorrell Lucy,Hanke Tomáš

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Lessons learned from HIV-1 vaccine trials: new priorities and directions;McMichael;Nat Immunol,2012

2. The T-cell response to HIV;Walker;Cold Spring Harb Perspect Med,2012

3. HIV-1-specific CTLs effectively suppress replication of HIV-1 in HIV-1-infected macrophages;Fujiwara;Blood,2007

4. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype;Sáez-Cirión;Proc Natl Acad Sci USA,2007

5. Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates;Spentzou;J Infect Dis,2010

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment;Frontiers in Immunology;2024-09-04

2. HIV Pol: does it offer therapeutic targets for HIV?;Expert Opinion on Therapeutic Targets;2024-05-03

3. Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses;Vaccines;2024-03-07

4. Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine;Cancer Immunology Research;2024-02-08

5. Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial;eBioMedicine;2024-02